Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-26

Clinical Trial Update: Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas

View source ↗

Summary

A completed clinical trial evaluated blood markers of reproductive hormones to assess ovarian reserve in younger patients with newly diagnosed lymphomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Oncology Group | Conditions: Anaplastic Large Cell Lymphoma, Burkitt Lymphoma | Status: COMPLETED